MOTS-c and Mitochondrial Optimisation: A Case Study Review

Mitochondrial health sits at the centre of nearly every longevity conversation. From energy production to metabolic flexibility and cellular resilience, the mitochondria ultimately determine how efficiently we age.

One emerging intervention that has gained attention in both research and biohacking circles is MOTS-c, a mitochondrial-derived peptide believed to regulate metabolic stress and enhance cellular efficiency. While preclinical data is promising, real-world human data remains limited.

In this article, we summarise four individual case studies using MOTS-c across 1-2 month cycles , examining its impact on mitochondrial biomarkers, energy regulation, and metabolic health.

What is MOTS-c?

MOTS-c is a peptide encoded within mitochondrial DNA. Unlike most peptides, which are nuclear-derived, MOTS-c acts as a mitochondrial signalling molecule, influencing:

• Glucose metabolism

• Insulin sensitivity

• Cellular stress responses

• Mitochondrial biogenesis and efficiency

Mechanistically, MOTS-c is thought to activate AMPK pathways, mimicking some effects of exercise and caloric restriction—two of the most well-established longevity interventions.

Study Design Overview

Across the four individuals:

• Cycle length: 4–9 weeks

• Dosing: Varied (reflecting real-world use rather than a fixed protocol)

• Measurements: Functional proteomics focusing on mitochondrial and energy-related markers

The goal was not to create a controlled trial, but rather to identify consistent directional trends in real-world use.

Key Finding #1: Mitochondrial Energy Production Improved

One of the most consistent findings across all four individuals between the three month TruHealth epigenetic tests was an improvement in markers related to mitochondrial energy production.

ATP Synthase (ATP5B)

ATP5B is a subunit of ATP synthase—the enzyme responsible for generating ATP, the body’s primary energy currency.

Across the cohort:

• Average improvement: +9.5 points

This suggests a more efficient ATP production system, which could translate into:

• Improved physical performance

• Better recovery

• Increased metabolic efficiency

Importantly, these changes reflected a normalisation toward optimal ranges, rather than excessive upregulation.

Key Finding #2: Mitochondrial Dynamics Became More Balanced

Another notable shift was seen in:

Dynamin-1-like protein (DRP1)

DRP1 plays a key role in mitochondrial fission, the process by which mitochondria divide.

While fission is necessary, excessive activity is often linked to:

• Mitochondrial fragmentation

• Cellular stress

• Reduced efficiency

Across the four individuals:

• Average normalisation: +13 points

This suggests MOTS-c may help restore balance between mitochondrial fission and fusion, supporting healthier mitochondrial networks and improved energy stability.

Key Finding #3: Broad Mitochondrial Stress Reduction

Looking more broadly, mitochondrial markers showed a consistent trend toward normalisation rather than overstimulation.

This is an important distinction.

Rather than pushing pathways aggressively, MOTS-c appears to act more as a regulator, helping the system return to a more optimal baseline. This aligns with its proposed role as a metabolic stress-response peptide, similar to signals activated during exercise or fasting.

Key Finding #4: Nutrient Interaction – The Riboflavin (Vitamin B2) Effect

One of the most interesting observations came from an individual who did not supplement vitamin B2 (riboflavin) during their MOTS-c cycle.

• Riboflavin levels dropped by 17%

Riboflavin is essential for:

• Electron transport chain function

• FAD/FMN cofactor production

• Mitochondrial energy metabolism

A likely explanation is that MOTS-c increases mitochondrial demand, leading to greater utilisation of key micronutrients.

In simple terms:

As mitochondrial efficiency improves, nutrient demand increases.

This highlights the importance of supporting mitochondrial cofactors, particularly B vitamins, when running a MOTS-c protocol.

Key Finding #5: Improvements in Epigenetic HbA1c

Another consistent trend across all four individuals was an improvement in epigenetic HbA1c, with reductions ranging from:

• 4% to 18%

What is HbA1c?

HbA1c (glycated haemoglobin) is a marker that reflects average blood glucose levels over the past 2–3 months. Higher levels indicate poorer glucose control and are associated with increased risk of:

• Insulin resistance

• Metabolic dysfunction

• Cardiovascular disease

Epigenetic HbA1c provides an additional layer of insight, reflecting how gene expression patterns align with long-term glucose regulation.

What This Means

The consistent reduction in HbA1c suggests that MOTS-c may:

• Improve glucose handling and insulin sensitivity

• Enhance metabolic flexibility

• Support a more favourable long-term metabolic profile

This aligns strongly with MOTS-c’s proposed activation of AMPK, a key regulator of glucose metabolism.

Case Study Summary

Across the four individuals, several consistent patterns emerged:

• ATP production improved (ATP5B ↑ ~9.5 points)

• Mitochondrial dynamics normalised (DRP1 ↑ ~13 points)

• Mitochondrial stress markers moved toward optimal ranges

• Epigenetic HbA1c decreased by 4–18%

• Increased nutrient demand observed, particularly for vitamin B2

Despite variations in dose and cycle length, the direction of change was highly consistent, strengthening the signal of a real physiological effect.

Practical Takeaways

From a practical standpoint, these case studies suggest that MOTS-c may:

1. Improve mitochondrial efficiency, rather than simply stimulating output

2. Enhance metabolic flexibility, particularly in glucose regulation

3. Require nutritional support, especially B vitamins

4. Work best as part of a broader longevity protocol

Final Thoughts

While these are small-scale observations, they offer valuable insight into how MOTS-c performs in real-world use.

Rather than acting as a blunt performance enhancer, MOTS-c appears to function as a metabolic regulator, improving efficiency across both mitochondrial and glucose pathways.

The combination of:

• Enhanced ATP production

• Improved mitochondrial dynamics

• Better glucose control

suggests a system that is not just working harder—but working more intelligently and sustainably.

As always, larger controlled studies are needed. But these early findings provide a compelling signal that MOTS-c may play a meaningful role in advanced longevity and metabolic optimisation strategies.

Disclaimer

The peptide referenced in this article, were sourced personally by 50% particpants from Elvian Labs, selected due to their provision of up-to-date independent testing for purity and microbial safety. This reference is provided for transparency only and does not constitute a recommendation, endorsement, or medical advice.

Any client results discussed are shared voluntarily by those individuals, based on peptides they chose to source and use under their own initiative.

Epic Genetics does not prescribe, recommend, supply, or advise on the use of peptides or other prescription-only substances.

The information presented is for educational and informational purposes only and should not be interpreted as medical guidance. Individuals are responsible for their own health decisions and should consult an appropriately qualified healthcare professional before using any pharmacological or peptide-based interventions.